Page 47 - Eshre Final Programme 2015

MONDAY 15 JUNE 2015
10:00 - 11:30 Porto
Selected oral communications: Session 03: PCOS: From laboratory to clinical science
Chairman: D. Romualdi (Italy) Chairman: A. Aguiar Cabral (Portugal)
10:00 O-009
The Neurokinin B Receptor Antagonist AZD4901 decreases LH and testosterone secretion in women with PCOS: a randomised, double-blind, placebo-controlled clinical trial
J.T. George1, R. Kakkar2, J.T. Marshall3, M.L. Scott4, R. Finkelman5, T.W. Ho6, S. McIntosh7,
J.D. Veldhuis8, R.A. Anderson9, L. Webber10
1University of Oxford, Oxford Centre for Diabetes Endocrinology and Metabolism -OCDEM, Oxford, United Kingdom
2AstraZeneca Pharmaceuticals, Innovative Medicines and Early Development, Waltham, U.S.A. 3AstraZeneca Pharmaceuticals, Biometrics Early Clinical Development, Cambridge, United Kingdom 4AstraZeneca Pharmaceuticals, Early Clinical Development, Waltham, U.S.A.
5Former AstraZeneca Employee, U.S.A.,
6AstraZeneca Pharmaceuticals, Global Product & Portfolio Strategy, Gaithersburg, U.S.A.
7Former AstraZeneca Employee, United Kingdom,
8Mayo Clinic, Endocrine Research Unit, Rochester, U.S.A.
9University of Edinburgh, MRC Centre for Reproductive Health, Edinburgh, United Kingdom
10AstraZeneca Pharmaceuticals, Innovative Medicines and Early Development, Manchester, United Kingdom
Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 months follow up period.
A. Elnashar1, H. El Maghraby2, T. Nafee3, D. Guiziry2, I. Fourtia4
1Benha University Hospital, Obs & Gyn, Mansoura, Egypt
2Alexandria University Hospital, Obs & Gyn, Alexandria, Egypt
3Keele University Medical School, Obs & Gyn, London, United Kingdom 4Fertility center, Obs & Gyn, Misrata, Libya
10:15 O-010
FINAL PROGRAMME I LISBON, PORTUGAL – 14 TO 17 JUNE 2015 47
SCIENTIFIC PROGRAMME MONDAY, 15 JUNE